Reduced COMMD1 expression in circulating leukocytes of IBD patients leads to heightened NF-κB transcriptional activity, while COMMD1 deficiency in myeloid cells exacerbates inflammatory responses. Here, NFKB1 is linked to inflammatory bowel disease.